FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Technoderma Medicines, Inc. ('the Company'), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...

NEW DELHI: Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic ...

Effective management of atopic dermatitis (AD) has been one of the top priorities ... with advancements paving the way for significant improvements in diagnostics, drug discovery, and personalised ...

At the recent SEC meeting for dermatology and allergy held on 5th and 6th December 2024, the expert panel reviewed the ...

Effective management of atopic dermatitis (AD) has been one of the ... paving the way for significant improvements in diagnostics, drug discovery, and personalised medicine. The application ...

INR:3309. icc t20 world cup 2024 prize money New dermatitis drug: Rinvoq shows promising clinical data in the treatment of ...

INR:4879. racing tv lir speciale Otsuka's new drug difamilast for atopic dermatitis reached its primary endpoint in both Phase III clinical trials CStone P ...